Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate 70518-3862-00
- Manufacturer
- Remedyrepack Inc.
- Dosage Form
- Tablet
- Route
- Sublingual
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- September 15, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA203326
Active Ingredients
| Ingredient | Strength |
|---|---|
| Buprenorphine Hydrochloride | 2 mg/1 |
| Naloxone Hydrochloride Dihydrate | .5 mg/1 |
Drug Class
Opioid Antagonist [EPC]Opioid Antagonists [MoA]Partial Opioid Agonist [EPC]
Selected Package
70518-3862-00Selected30 TABLET in 1 BLISTER PACK (70518-3862-0)
External Resources